Labeling Type
HUMAN PRESCRIPTION DRUG LABEL
Status
Approved
Full Title
AMYTAL SODIUM CII (amobarbital sodium) FOR INJECTION, USP Vials CAUTION: These products are to be used under the direction of a physician. The intravenous administration of AMYTAL SODIUM (amobarbital sodium) FOR INJECTION, USP carries with it the potential dangers inherent in the intravenous use of any potent hypnotic.
United States
Data Sources & Disclaimer: Approval information is sourced from official FDA databases. This content is for informational purposes only and does not constitute medical or regulatory advice. Always refer to official FDA websites for the most current information.
